CIK 0001010086
- Accelerated filer
SIGA TECHNOLOGIES INC
Sign in to watch- Ticker
- SIGA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133864870
- Phone
- +1 212-672-9100
- Business address
- 31 EAST 62ND STREET, NEW YORK, NY, 10065
- Former names
- SIGA PHARMACEUTICALS INC
- 4 Open-market sale Director sold 30,000 shares at $5.70 ($171,000)
- 4 Open-market sale VP & Chief Scientific Officer sold 50,000 shares at an average $5.61 ($280,530)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 25,000 shares (option exercise)
- 4 Exercise or conversion Executive VP & CFO acquired 58,965 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 105,896 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 287,543 shares (to pay taxes)
- 4 Open-market buy Director bought 5,000 shares at $5.58 ($27,900)
- 4 Open-market sale VP & Chief Scientific Officer sold 50,000 shares at an average $5.17 ($258,263)
- 4 Open-market buy Chief Executive Officer bought 15,000 shares at $5.20 ($78,000)
- 4 Open-market buy Director bought 10,000 shares at $5.01 ($50,100)
Page 7 of 25 · 495 filings